Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 2 · 66.7%High 0 · 0%

Corticosteroid related adverse events · Patients with active Crohn's disease

Budesonide 15 mg showed no clear difference in corticosteroid related adverse events compared with placebo (moderate certainty).

1 finding from 1 review

Budesonide for induction of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 1.4 [0.84, 2.34]
2 studies · 181 participants
Moderate

Corticosteroid related adverse events · Patients with active Crohn's disease

Budesonide 3 mg showed no clear difference in corticosteroid related adverse events compared with placebo (low certainty).

1 finding from 1 review

Budesonide for induction of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 0.58 [0.29, 1.17]
1 study · 133 participants
Low

Corticosteroid related adverse events · Patients with active Crohn's disease

Budesonide 9 mg showed no clear difference in corticosteroid related adverse events compared with placebo (moderate certainty).

1 finding from 1 review

Budesonide for induction of remission in Crohn's disease 2015 · Cochrane Headline outcomes only
RR 0.97 [0.76, 1.23]
3 studies · 384 participants
Moderate